Gastric Cancer Patient-Derived Organoids Model for the Therapeutic Drug Screening

0
29
Patient-derived organoids (PDOs) were established from surgically resected gastric cancer tumor tissues. Histological and molecular characterization of PDOs and primary tissues were performed via IHC and sequencing analysis.
[Biochimica Et Biophysica Acta-General Subjects]
Abstract